Bio-Rad Laboratories A

Bio-Rad Laboratories Shares Fall Below 200-Day Moving Average

BioRad实验室A

Bio-Rad Laboratories A's 15min chart shows MACD and KDJ Death Cross signals.

Bio-Rad Q4 revenue up 2% YoY, FY23 revenue up 1% YoY

Bio-Rad Laboratories A: MACD Death Cross, KDJ Death Cross on 15min chart.

Catalyst<ul> <li>Most analysts rate BIO Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state, and the direction is not clear enough.</li> <li>Large and Extra-large fund flows show negative trends, indicating potential outflows from major investors.</li></ul>

Key Factors

Bio-Rad Laboratories (BIO) shares fell below their 200-day moving average of $281.97, reaching a low of $251.00 per share on February 13, 2026.

BIO News